Mersana Therapeutics
MRSN
#8913
Rank
โ‚ฌ0.11 B
Marketcap
23,94ย โ‚ฌ
Share price
-0.85%
Change (1 day)
-60.36%
Change (1 year)

Revenue for Mersana Therapeutics (MRSN)

Revenue in 2025 (TTM): โ‚ฌ32.17 Million

According to Mersana Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ29.83 Million. In 2024 the company made a revenue of โ‚ฌ38.91 Million an increase over the revenue in the year 2023 that were of โ‚ฌ33.33 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Mersana Therapeutics from 2016 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ32.17 M-17.33%
2024 โ‚ฌ38.91 M16.73%
2023 โ‚ฌ33.33 M34.54%
2022 โ‚ฌ24.78 M63680.85%
2021 โ‚ฌ0.03 M-94.24%
2020 โ‚ฌ0.67 M-98.21%
2019 โ‚ฌ37.6 M306.01%
2018 โ‚ฌ9.26 M-36.66%
2017 โ‚ฌ14.62 M-38.89%
2016 โ‚ฌ23.92 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA